ATE266097T1 - Infectiösenbursalkrankheitsvirus (ibdv) die an zellkultur angepasst sind - Google Patents

Infectiösenbursalkrankheitsvirus (ibdv) die an zellkultur angepasst sind

Info

Publication number
ATE266097T1
ATE266097T1 AT00200709T AT00200709T ATE266097T1 AT E266097 T1 ATE266097 T1 AT E266097T1 AT 00200709 T AT00200709 T AT 00200709T AT 00200709 T AT00200709 T AT 00200709T AT E266097 T1 ATE266097 T1 AT E266097T1
Authority
AT
Austria
Prior art keywords
ibdv
cell culture
bursal disease
infectious bursal
disease virus
Prior art date
Application number
AT00200709T
Other languages
English (en)
Inventor
Adriaan Antonius Wilhelmus Maria Loon
Egbert Mundt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE266097T1 publication Critical patent/ATE266097T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00200709T 1999-03-05 2000-02-28 Infectiösenbursalkrankheitsvirus (ibdv) die an zellkultur angepasst sind ATE266097T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200647 1999-03-05

Publications (1)

Publication Number Publication Date
ATE266097T1 true ATE266097T1 (de) 2004-05-15

Family

ID=8239949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00200709T ATE266097T1 (de) 1999-03-05 2000-02-28 Infectiösenbursalkrankheitsvirus (ibdv) die an zellkultur angepasst sind

Country Status (14)

Country Link
US (2) US6492148B1 (de)
EP (1) EP1035203B1 (de)
JP (2) JP4675447B2 (de)
KR (1) KR100709077B1 (de)
AT (1) ATE266097T1 (de)
BR (1) BR0001011B1 (de)
CA (1) CA2298956C (de)
DE (1) DE60010358T2 (de)
DK (1) DK1035203T3 (de)
ES (1) ES2220333T3 (de)
HU (1) HU226254B1 (de)
PL (1) PL198981B1 (de)
PT (1) PT1035203E (de)
ZA (1) ZA200001069B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
CN1592794A (zh) * 2001-03-09 2005-03-09 加利福尼亚大学董事会 用于合成感染性丙型肝炎病毒的细胞培养系统
WO2003035824A1 (en) * 2001-10-25 2003-05-01 Bar-Ilan University Interactive transparent individual cells biochip processor
IL154677A0 (en) 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US9200245B2 (en) * 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
US8597597B2 (en) 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US20060240548A1 (en) * 2003-06-26 2006-10-26 Mordechai Deutsch Materials for constructing cell-chips, cell-chip covers, cell-chips coats, processed cell-chips and uses thereof
US7888110B2 (en) 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
WO2005008626A1 (en) * 2003-07-11 2005-01-27 University Of North Carolina At Chapel Hill Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
JP2007520546A (ja) * 2004-02-03 2007-07-26 ケマジス リミティド モンテルカストナトリウムの安定な非晶質性形態
EP1763665A1 (de) * 2004-07-07 2007-03-21 Seng Enterprises Limited Verfahren und vorrichtung zur identifizierung eines vertiefungsbildes auf einem bild einer komponente mit vertiefungen
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
EP1781404A2 (de) * 2004-08-25 2007-05-09 Seng Enterprises Limited Verfahren und vorrichtung zur isolierung von zellen
ATE480324T1 (de) 2005-01-25 2010-09-15 Seng Entpr Ltd Mikrofluidische vorrichtung zur untersuchung zellen
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
US8288120B2 (en) 2005-11-03 2012-10-16 Seng Enterprises Ltd. Method for studying floating, living cells
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
WO2009081409A2 (en) 2007-12-26 2009-07-02 Seng Enterprises Ltd. Device for the study of living cells
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
EP2407534A1 (de) 2010-07-14 2012-01-18 Neo Virnatech, S.L. Verfahren und Reagenzien zum Erhalt von transkriptionell aktiven virusähnlichen Artikeln und rekombinante Virionen
CN102258777B (zh) * 2011-06-30 2012-09-26 河南农业大学禽病研究所 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法
CN111235117B (zh) * 2020-02-13 2021-08-27 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一株自然适应体外细胞培养的鸡传染性法氏囊病病毒经典株及其应用
TWI862969B (zh) * 2022-08-23 2024-11-21 財團法人紡織產業綜合研究所 液態色母組合物及彩色纖維的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
HUP0000992A2 (hu) 2000-11-28
ES2220333T3 (es) 2004-12-16
DK1035203T3 (da) 2004-08-30
ZA200001069B (en) 2000-10-20
PL198981B1 (pl) 2008-08-29
EP1035203A1 (de) 2000-09-13
US6492148B1 (en) 2002-12-10
KR20010069175A (ko) 2001-07-23
JP4675447B2 (ja) 2011-04-20
PL338773A1 (en) 2000-09-11
PT1035203E (pt) 2004-08-31
HUP0000992A3 (en) 2005-06-28
CA2298956C (en) 2009-12-01
JP2000312593A (ja) 2000-11-14
HU226254B1 (en) 2008-07-28
EP1035203B1 (de) 2004-05-06
DE60010358T2 (de) 2004-09-23
KR100709077B1 (ko) 2007-04-19
US6569422B1 (en) 2003-05-27
CA2298956A1 (en) 2000-09-05
JP2011036255A (ja) 2011-02-24
DE60010358D1 (de) 2004-06-09
HU0000992D0 (en) 2000-05-28
BR0001011A (pt) 2001-07-03
BR0001011B1 (pt) 2011-05-17

Similar Documents

Publication Publication Date Title
ATE266097T1 (de) Infectiösenbursalkrankheitsvirus (ibdv) die an zellkultur angepasst sind
EP1394259A3 (de) Rekombinantes infektiöses nicht-in-Segmente-geteiltes negativ-Strange-RNS-Virus
DE69133597D1 (de) Cytoplasmatische männliche Sterilität verleihende Dna-Sequenz, mitochondriales Genom, nukleäres Genom, Mitochondrien und diese Sequenz enthaltende Pflanze, und Verfahren zur Herstellung von Hybriden
HUP0000188A2 (hu) Immortalizált sejtvonalak vírusszaporításra
PL333070A1 (en) Infectious clones of rna viruses and vaccines based on them
NZ326555A (en) Inhibitors of interleukin-1beta converting enzyme (ICE)
DE69534785D1 (en) Pflanzen lysophosphatidesäure-acyltransferase
DE69637631D1 (de) Künstliche säuger chromosome
CA2226293A1 (en) Hcv ns3 protein fragments having helicase activity and improved solubility
AU4691589A (en) Feline infectious peritonitis virus diagnostic tools
DE60004217D1 (de) Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon
DE69329500D1 (de) Ein verfahren zur herstellung von immunosuppressiva und eine neuartige mikrobielle spezies, die dabei eingesetzt wird
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ATE187496T1 (de) Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen
DE69404615D1 (de) Verfahren zur Herstellung 1,2-Benzisothiazol-3-one
DE3587205D1 (de) Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
ATE199397T1 (de) Multiple virus-resistenz aufweisende transgene pflanzen und verfahren zu ihrer herstellung
ATE209683T1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
ATE282088T1 (de) Aminopeptidase, welche von bacillus licheniformis abstammt und verfahren zur herstellung von proteinen des natürlichen typs
DE60036198D1 (de) Transgener mollusk und verfahren zu seiner herstellung
DE68913212D1 (de) Ein reines faktor i-protein und verfahren zur herstellung.
DE69934329D1 (de) Verfahren zur genetischen veränderung einer viralen wildtyp-sequenz
Davidson Robots: the next generation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties